Showing results (1121-1130 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|December 8, 2018
Progress in Developing Pharmacologic Agents to Treat Bulimia NervosaSusan L McElroy, Anna I Guerdjikova, Nicole Mori, et al.CNS Drugs|November 26, 2021
Pharmacokinetics, Safety, and Tolerability of SHP465 Mixed Amphetamine Salts After Administration of Multiple Daily Doses in Children Aged 4-5 Years with Attention-Deficit/Hyperactivity DisorderKatarina Ilic, Alan R Kugler, Brian Yan, et al.CNS Drugs|February 19, 2021
Psychotropic Drug-Induced Glaucoma: A Practical Guide to Diagnosis and ManagementNeeranjali S Jain, Claire W Ruan, Shanil R Dhanji, et al.CNS Drugs|September 25, 2019
Recent Advances in the Drug Treatment of Dravet SyndromeElaine C Wirrell, Rima NabboutCNS Drugs|September 27, 2019
Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative DisordersNiels Bergsland, Eleonora Tavazzi, Ferdinand Schweser, et al.CNS Drugs|May 6, 2014
Role of atypical antipsychotics in the treatment of generalized anxiety disorderRachel Hershenberg, Daniel F Gros, Olga Brawman-MintzerCNS Drugs|April 12, 2017
Managing Negative Symptoms of Schizophrenia: How Far Have We Come?Joshua T KantrowitzCNS Drugs|November 12, 2021
Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use DisordersRuyan Wu, Jun-Xu LiCNS Drugs|November 25, 2021
Time to Onset of Response to Pitolisant for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients With Narcolepsy: An Analysis of Randomized, Placebo-Controlled TrialsNathaniel F Watson, Craig W Davis, Donna Zarycranski, et al.Pageof 211